Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma

Journal of Neuro-Oncology

Volumn 71, Issue 3, 2005, Pages 315-318

  Su, Ying Wen ^a   Chang, Ming Chih ^a,b   Chiang, Ming Fu ^a,b   Hsieh, Ruey Kuen ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b Mackay Junior School of Nursing   (Taiwan)

Author keywords

Recurrent glioma; Secondary myelodysplastic syndrome; Temozolomide

Indexed keywords

CD14 ANTIGEN; CD2 ANTIGEN; CD33 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; IDARUBICIN; INTERFERON; MICROSOMAL AMINOPEPTIDASE; NIMUSTINE; TEMOZOLOMIDE; THALIDOMIDE;

ACUTE LEUKEMIA; ADULT; ANEMIA; ARTICLE; BLOOD TOXICITY; BONE MARROW BIOPSY; BRAIN EDEMA; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CASE REPORT; CHROMOSOME 3Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME DELETION 3; DISEASE COURSE; DISEASE SEVERITY; FEBRILE NEUTROPENIA; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GLIOBLASTOMA; HUMAN; LEUKOPENIA; MORTALITY; MYELODYSPLASTIC SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCYTOPENIA; PROGNOSIS; QUALITY OF LIFE; RADIOSURGERY; RECURRENT CANCER; REFRACTORY ANEMIA WITH EXCESS BLASTS; SYMPTOMATOLOGY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; ASTROCYTOMA; BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 11; DACARBAZINE; FATAL OUTCOME; FEMALE; GENE DELETION; HUMANS; LEUKEMIA; MYELODYSPLASTIC SYNDROMES; NEOPLASM RECURRENCE, LOCAL;

EID: 14944377007     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11060-004-2028-0     Document Type: Article

References (35)

1. MF Greaves 1997 Aetiology of acute leukemia Lancet 349 344 349
2. ET Wong KR Hess MJ Gleason KA Jaeckle AP Kyritsis MD Prados VA Levin WK Yung 1999 Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol 17(8) 2572
3. RE Curtis JD Boice M Stovall L Bernstein RS Greenberg JT Flannery AG Schwartz P Weyer WC Moloney RN Hoover 1992 Risk of leukemia after chemotherapy and radiation treatment for breast cancer N Engl J Med 326 26 1745-1751, 1992
4. MH Greene JD Boice TA Strike Jr 1985 Carmustine as a cause of acute nonlymphocytic leukemia N Engl J Med 313 9 579
5. DR Macdonald 2001 Temozolomide for recurrent high-grade glioma Semin Oncol 28 4 Suppl 13 3-12
6. WK Yung 2000 Temozolomide in malignant gliomas Semin Oncol 27 3 Suppl 6 27-34
7. WK Yung RE Albright J Olson R Fredericks K Fink MD Prados M Brada A Spence RJ Hohl W Shapiro M Glantz H Greenberg RG Selker NA Vick R Rampling H Friedman P Phillips J Bruner N Yue D Osoba S Zaknoen VA Levin 2000 A phase II study of temozolomide vs procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83 5 588-593
8. G Robustelli della Cuna P Paoletti G Bernardo R Knerich G Butti Q Cuzzoni 1982 Clinical toxicity of combined modality treatment with nitrosourea derivatives for central nervous system tumors Neurosurgery 11 3 408-411
9. J Hildebrand M Malarme J Flament-Durand P Stryckmans 1982 Acute nonlymphoblastic leukemia in a patient treated for brain tumor Arch Neurol 39 10 664-665
10. JY Genot M Krulik M Poisson R Efferterre van M Renoux AA Audebert C Canuel N Smadja J Debray 1983 Two cases of acute leukemia following treatment of malignant glioma Cancer 52 2 222-226
11. S Kempin N Sundaresan WB Shapiro Z Arlin 1984 Acute nonlymphocytic leukemia following treatment of malignant glioma Report of two cases. J Neurosurg 60 6 1287-1290
12. J Blatt L Penchansky C Phebus M Horn 1991 Leukemia in a child with a history of medulloblastoma Pediatric Hematol Oncol 8 1 77-82
13. HM Kantarjian MJ Keating RS Walters TL Smith A Cork KB McCredie EJ Freireich 1986 Therapy-related leukemia and myelodysplastic sundrome: clinical, cytogenetic, and prognostic features J Clin Oncol 4 12 1748-1757
14. JD Rowley HM Golomb JW Vardiman 1981 Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease Blood 58 4 759-767
15. MJ Thirman RA Larrson 1996 Therapy-related myeloid leukemia Hematol Oncol Clin N Am 10 2 293-320
16. WK Yung MD Prados R Yaya-Tur SS Rosenfeld M Brada HS Friedman R Albright J Olson SM Chang AM O'Neill AH Friedman J Bruner N Yue M Dugan S Zaknoen VA Levin 1999 Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse Temodal Brain Tumor Group J Clin Oncol 17 9 2762-2771 1:CAS:528:DyaK1MXmtlWru7s%3D 10561351
17. M Arakawa F Shimizu N Okda 1974 Effect of 1-(4-amino-2-methyl-pyrimidin-5-yl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride on leukemia L-1210 Jpn J Cancer Res 65-191
18. M Kazuo M Tomohiko S Masaki H Kiyohiko A Youichi M Yasusada 1996 Therapy-related chronic myelomonocytic leukemia with bone marrow eosinophilia associated with der (11) t(1;11)(q21;q14) Acta Hematol 96 4 25-254
19. N Masami B Shuji T Taizo F Mitsuhiro Y Amane K Hiroko F Yasunobu Y Genji T Jiro 1999 Secondary myeloid/natural killer cell precursor acute leukemia following essential thrombocythemia Hum Pathol 30 7 868-871
20. F Oshita T Tamura A Kojima K Yamada M Fukuda K Nakagawa Y Ohe Y Sasaki K Eguchi T Shinkai 1991 Late toxicities and complications in three-year survivors of small cell lung cancer Eur J Cancer 27 4 427-430
21. T Kageshita N Kuribayashi T Ono 2000 Myelodysplastic syndrome following treatment of malignant melanoma with vincristine, ACNU, and dacarbazine J Dermatol 27 3 178-180
22. MJ Laughlin DS McGaughey JR Crews NJ Chao D Rizzieri M Ross J Gockerman C Cirrincione D Berry L Mills P Defusco S LeGrand WP Peters JJ Vredenburgh 1998 Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant J Clin Oncol 16 3 1008-1012
23. MJ Bent van den O Chinot W Boogerd J Bravo Marques MJ Taphoorn JM Kros CC Rijt van der CJ Vecht N Beule De B Baron 2003 Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972 Ann Oncol 14 4 599-602
24. R Stupp PY Dietrich S Ostermann Kraljevic A Pica I Maillard P Maeder R Meuli R Janzer G Pizzolato R Miralbell F Porchet L Regli N Tribolet de RO Mirimanoff S Leyvraz 2002 Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide J Clin Oncol 20 5 1375-1382 10.1200/JCO.20.5.1375 1:CAS:528:DC%2BD38XisVWmu7s%3D 11870182
25. JD Boice MH Greene JY Killen Jr SS Ellenberg JF Fraumeni Jr RJ Keehn E McFadden TT Chen D Stablein 1986 Leukemia after adjuvant chemotherapy with semustine (methyl-CCNU) - evidence of a dose-response effect N Engl J Med 314 2 119-120
26. S Devereux TG Selassie G Vaughan Hudson B Vaughan Hudson DC Linch 1990 Leukaemia complicating treatment for Hodgkin's disease: The experience of the British National Lymphoma Investigation Br Med J 301 6760 1077-1080
27. JR Perry MT Brown JP Gockerman 1998 Acute leukemia following treatment of malignant glioma J Neurooncol 40 1 39-46 10.1023/A:1006175831785 1:STN:280:DyaK1M%2FovFGrsg%3D%3D 9874184
28. B Johansson F Mertens F Mitelman 1996 Primary vs secondary neoplasia associated chromosomal abnormalities - balanced rearrangements vs. genomic imbalances? Gene Chromosome Cancer 16 3 155-163
29. C Lengauer KW Kinzler B Vogelstein 1998 Genetic instabilities in human cancers Nature 396 6712 643-649 10.1038/25292 1:CAS:528:DyaK1MXisVWqsQ%3D%3D
30. T Yamaguchi J Toguchida T Yamamuro Y Kotoura N Takada N Kawaguchi Y Kaneko Y Nakanura MS Sasaki K Ishizaki 1992 Allelotype analysis in osteosarcomas: Frequent allele loss on 3q, 13q, 17p, and 18q Cancer Res 52 2419-2423
31. E Edstrom E Mahlamaki B Nord M Kjellman R Karhu A Hoog N Goncharov BT Teh M Backdahl C Larsson 2000 Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology Am J Pathol 156 651-659
32. F Tschentscher G Prescher DE Horsman VA White H Rieder G Anastassiou H Schilling N Bornfeld KU Bartz-Schmidt B Horsthemke DR Lohmann M Zeschnigk 2001 Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma Cancer Res 61 8 3439-3442
33. AI Neugut E Robinson J Nieves T Murray WY Tsai 1990 Poor survival of treatment-related acute nonlymphocytic leukemia JAMA 264 8 1006-1008
34. C Strupp U Germing M Aivado E Misgeld R Haas N Gattermann 2002 Thalidomide for the treatment of patients with myelodysplastic syndromes Leukemia 16 1 1-6
35. A Badros C Morris M Zangari B Barlogie G Tricot 2002 Thalidomide paradoxical effect on concomitant multiple myeloma and myelodysplasia Leukemia Lymphoma 43 6 1267-1271